Search results
Results from the WOW.Com Content Network
It is run by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Commission on Human Medicines. It was extended to hospital pharmacists in 1997, and to community pharmacists in 1999. [2] The Yellow Card Centre Scotland is a joint venture between MHRA and the Scottish Government. [3]
The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices. There are currently eight such committees: [citation needed] Advisory Board on the Registration of Homeopathic Products; Herbal Medicines Advisory Committee; The Review Panel
The application is intended to replace the existing paper-based method of providing proof of vaccination in international travel, colloquially known as the Yellow Card. Trials of the application are carried out by a number of airlines including Singapore Airlines , Emirates , Qatar Airways , Etihad and Air New Zealand .
The Medicines and Healthcare products Regulatory Agency (MHRA) and the Commission on Human Medicines (CHM) jointly operate the Yellow Card Scheme, which was one of the first examples of a pharmacovigilance scheme, aimed at mitigating adverse drug reactions (ADRs). [citation needed]
The ICVP's nickname Yellow Card or its French equivalent Carte Jaune derives from the yellow colour of the document. The fact that yellow fever is a commonly required vaccination for travel has contributed to the document's association with the colour yellow, even though the ICVP can cover a wide range of vaccinations and booster shots, not just yellow fever.
On 2 December 2020, the UK became the first country to give approval for use of the Pfizer–BioNTech vaccine, [36] [37] later branded as Comirnaty. [38] This was in the form of a temporary authorisation given by the Medicines and Healthcare products Regulatory Agency (MHRA) under Regulation 174 of the Human Medicines Regulations 2012. [39]
News. Science & Tech
The Commission on Human Medicines (CHM) is a committee of the UK's Medicines and Healthcare products Regulatory Agency. It was formed in October 2005, and assumed the responsibilities of the Medicines Commission and the Committee on Safety of Medicines. Membership in this various and extensive body is listed on a governmental website.